Premium
Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium‐glucose cotransporter 2 inhibitor – SGLT2‐inhibitor)
Author(s) -
Moldenhauer I.,
Pliquett R.U.,
Kreft B.,
Sunderkötter C.
Publication year - 2019
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/ddg.13807
Subject(s) - venereology , medicine , empagliflozin , family medicine , dermatology , diabetes mellitus , type 2 diabetes , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom